MNVRX Mutual Fund

MNVRX Mutual Fund

NAV$30.95
See how much of MNVRX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Apr 30, 2026

Net Assets
$42M
Expense Ratio
0.73%
Dividend Yield (Current)
6.91%
Holdings
30
Inception Date
Sep 23, 2013
Fund Family
Madison Funds
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+7.89%
1 Year+12.48%
3 Year+10.83%
5 Year+8.83%
10 Year+12.46%

Asset Allocation

Stocks: 100.01%
See how much of MNVRX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report is $25, once. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
AMZNAmazon.Com Inc6.08%
ACGL:BMArch Capital Group Ltd.5.92%
ADIAnalog Devices, Inc.4.67%
AAgilent Technologies Inc3.14%
ABNBAirbnb Inc2.69%
Top 10 Concentration: 25.91%Report Date: Apr 30, 2026
Download all 30 holdings for MNVRX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
6.91%
Frequency
Annually
Latest Distribution
$2.29
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

MNVRX Mutual Fund Overview

MNVRX Mutual Fund (Madison Investors Fund Cl R6) is managed by Madison Funds with $42.4M in net assets. MNVRX expense ratio is 0.73%, holding 30 positions across sectors including Information Technology, Consumer Discretionary. Inception date: 2013-09-23.

MNVRX performance shows a YTD return of 7.89%. The 1-year return is 12.48% and the 5-year return is 8.83%. MNVRX dividend yield stands at 6.91%, paid annually.

MNVRX top holdings include Amazon.Com Inc (6.1%), Arch Capital Group Ltd. (5.9%), Analog Devices, Inc. (4.7%), Agilent Technologies Inc (3.1%), Airbnb Inc (2.7%). Go to all MNVRX holdings, MNVRX sectors, or MNVRX dividends.

MNVRX can be compared against other funds. Use MNVRX overlap to find shared positions, or MNVRX vs another fund for a side-by-side view. MNVRX alternatives are available via the screener, along with tax-loss harvesting opportunities.